BGS Career Development

Making It Count!

Rebecca Lopez

BGSA & IGA: Science Communication and Activism Career Panel

by


BGSA & IGA are co-hosting Science Communication and Activism Career Panel.  Panelists will include Wei Ji Ma PhD (professor and science activist), Evguenia Alechine PhD (medical and science writer), and Kevin Alicea PhD (associate director of PROUD and science activist) who are involved in careers focusing on science communication and activism.  The virtual event will be hosted on Monday, March 1st, 12-1pm.

Please submit any questions you may want to ask the panelists using the google form and sign up to be entered in a raffle for the BGSA sweatshirt: https://forms.gle/ozTYKP5SWggQHs2b9

Panelist bios attached!

Postdoctoral Position at Columbia University

by

Ciccia laboratory, Columbia University Medical Center

A postdoctoral position is available in Alberto Ciccia’s laboratory in the Department of Genetics and Development at Columbia University Irving Medical Center.

See the full description here.

To apply for this position, please submit a cover letter describing research experience and interests, CV and contact information of three references to: 

Alberto Ciccia
Associate Professor
Department of Genetics and Development
Irving Cancer Research Center
Columbia University Irving Medical Center
ac3685@cumc.columbia.edu

Industry Scientist Opportunities for Recent Graduates

by

Aro Biotherapeutics Announces $88 Million Series A Financing to Advance Development of Centyrin-Targeted Genetic Medicines | Business Wire

About Aro BioTx  

Join the team at Aro Biotherapeutics creating breakthrough biotherapeutics based on Centyrin oligonucleotide conjugates.  Centyrins are small protein domains based on the fibronectin domains of human Tenascin C that combine the affinity and specificity properties of antibodies with the stability and tissue penetration properties of small molecules.  We have engineered Centyrins with an array of specificities for normal and immune cell receptors.  By linking Centyrin domains together genetically, we have created multi-specific binders that retain a small footprint to enable excellent tissue penetration.  Engineered for high stability, multi-specific Centyrins are readily expressed and purified from E. coli or mammalian cells.

Aro BioTx has two open positions; see the online applications here:

You can also read the position descriptions here.

Interested candidates may reach out to:
Zhonghao (John) Liu, Ph.D.
VP, Biology & New Target Evaluation
Aro Biotherapeutics
jliu@arobiotx.com

FitzGerald Lab Opportunities – Graduate Students & Postdocs

by


The FitzGerald lab has opportunities in its two areas of interest – bioactive lipids and the molecular clock.

In the first, current projects are focused on defining the role of eicosanoids and other bioactive lipids in cardiopulmonary disease, pain, the response to checkpoint blockade in cancer, aging and in viral infections, such as in COVID-19.

Our work on molecular clocks includes the integration of multi-omics and remote sensing data to define the human chronobiome in aging and in time dependent disease phenotypes such as non-dipping hypertension and asthma. We are also interested in the mechanisms which underlie sexual dimorphism in chronobiology and in using mass spec imaging and single cell biology to study circadian phenotypes in mice.

Overall, we are a group of around 30 from varied backgrounds including clinical medicine, informatics, mass spectrometry, genetics, metabolism, molecular and cell biology. A driving feature of our research is to integrate studies in model systems – mice, zebrafish, organoids, iPSC cells – with the deep and perturbed phenotyping possible in experimental medicine at the Center for Human Phenomic Science and the capacity to address hypotheses at scale using resources such as the Penn Medicine and UK Biobanks.

Please contact Garret FitzGerald (garret@upenn.edu).

Seres Therapeutics seeking Scientist, Analytical Development

by

Image result for seres therapeutics

Scientist, Analytical Development
Online Job Application

Seres Therapeutics is well-positioned to become the first company to bring an approved microbiome drug to patients through our proprietary discovery and design platform.  We identify key alterations in the microbiome that are associated with specific diseases and are designing live bacterial ecologies to act as therapeutics in areas as diverse as infectious and inflammatory disease, immune regulation, and immuno-oncology.

The Scientist, Analytical Development will work closely with our Analytical Development, Quality Control, and Research & Development teams in the development of microbial and molecular assays to ensure safe and effective bacterial therapeutics for the patients who need them.  This is a fantastic opportunity for a creative scientist who can apply their expertise to the unique challenges faced when characterizing and releasing therapeutics comprised of communities of bacteria. 

What’s in it for you?

This is an opportunity to have a significant impact on the development of a novel class of therapeutics for various disease areas while learning about the exciting science of the microbiome and its impact on human health and disease.  

How do you know if you’re the right fit?

This is an incredible opportunity for someone who will get excited about developing assays that are robust and capable of supporting key decisions to move our programs forward.  If you are flexible and driven, have worked in a fast-paced organization, and enjoy the challenge of forging a path forward in a new field, you would find this novel opportunity very engaging.  

In order to develop the sorts of assays Seres needs, you should be a PhD-level scientist, or equivalent, with significant assay development experience in the area of molecular biology and/or microbiology.   You should have an excellent attitude with an infectious excitement around learning and teaching your craft.   Experience with assay qualification or validation is a plus. Other desirable skills include sequencing, qPCR/dPCR, probe-based hybridization assays, LC-MS, IC, and automated liquid handlers.